Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs against diseases of the central nervous system (CNS). Because of this barrier there is still a huge unmet need for the treatment of these diseases, despite years of research efforts across the pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Axel H., Feldsien, Thomas M., Mezler, Mario, Untucht, Christopher, Venugopalan, Ramakrishna, Lefebvre, Didier R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145602/
https://www.ncbi.nlm.nih.gov/pubmed/37111587
http://dx.doi.org/10.3390/pharmaceutics15041100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145602/
https://www.ncbi.nlm.nih.gov/pubmed/37111587
http://dx.doi.org/10.3390/pharmaceutics15041100

Ejemplares similares